What's new

Human medicines European public assessment report (EPAR): Evrenzo, roxadustat, Date of authorisation: 18/08/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Evrenzo, roxadustat, Date of authorisation: 18/08/2021, Revision: 6, Status: Authorised

Apr 8, 2025 - 13:44
 0
Human medicines European public assessment report (EPAR): Evrenzo, roxadustat, Date of authorisation: 18/08/2021, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Evrenzo, roxadustat, Date of authorisation: 18/08/2021, Revision: 6, Status: Authorised
Read More

Tags:

Previous Article

KalVista, awaiting FDA call on HAE drug, sells Japanese rights to Kaken in $22M ...

Next Article

Bangladesh offers nil tariffs on 100 more US goods to narrow trade gap

Related Posts

Questions and answers clinic on post-authorisation procedure management in IRIS - 17 Jan 2025, Online, from 17 January 2025, 10:00 (CET) to 17 January 2025, 11:00 (CET)

Questions and answers clinic on post-authorisation proc...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): INOmax, nitric oxide, Date of authorisation: 01/08/2001, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0

Human medicines European public assessment report (EPAR): Rapamune, sirolimus, Date of authorisation: 13/03/2001, Revision: 48, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0